373 GENES FOUNDi
Show / hide columns XML | RDF | TSV | Page of 8 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x Prognostic p-valuei x RNA tissue categoryi x
ABCB1ATP binding cassette subfamily B member 1Cancer-related genes
CD markers
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Nucleoplasm
Focal adhesion sites
Cytosol
Renal cancer: 2.95e-4
Pancreatic cancer: 3.33e-4
Tissue enhanced
ABCG2ATP binding cassette subfamily G member 2 (Junior blood group)Cancer-related genes
CD markers
Predicted intracellular proteins
Predicted membrane proteins
Nucleus
Plasma membrane
Tissue enhanced
ACEAngiotensin I converting enzymeCandidate cardiovascular disease genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
VesiclesTissue enhanced
ACKR1Atypical chemokine receptor 1 (Duffy blood group)Blood group antigen proteins
CD markers
G-protein coupled receptors
Predicted membrane proteins
Cervical cancer: 2.52e-5
Liver cancer: 1.48e-4
Thyroid cancer: 9.76e-4
Mixed
ADAM10ADAM metallopeptidase domain 10Cancer-related genes
CD markers
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Vesicles
Plasma membrane
Lung cancer: 8.46e-5
Pancreatic cancer: 1.90e-4
Expressed in all
ADAM17ADAM metallopeptidase domain 17CD markers
Disease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
CytosolUrothelial cancer: 4.23e-5
Expressed in all
ADAM8ADAM metallopeptidase domain 8CD markers
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Renal cancer: 3.99e-10
Tissue enhanced
ADGRE2Adhesion G protein-coupled receptor E2CD markers
G-protein coupled receptors
Predicted membrane proteins
VesiclesRenal cancer: 4.35e-6
Tissue enhanced
ADGRE5Adhesion G protein-coupled receptor E5CD markers
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
CytosolRenal cancer: 1.87e-6
Liver cancer: 3.73e-5
Expressed in all
ALCAMActivated leukocyte cell adhesion moleculeCancer-related genes
CD markers
Plasma proteins
Predicted membrane proteins
Renal cancer: 3.15e-4
Tissue enhanced
ALKAnaplastic lymphoma receptor tyrosine kinaseCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Plasma membraneTissue enhanced
ANPEPAlanyl aminopeptidase, membraneCD markers
Enzymes
Plasma proteins
Predicted membrane proteins
Plasma membraneGroup enriched
ART1ADP-ribosyltransferase 1CD markers
Enzymes
Predicted membrane proteins
Tissue enriched
ART4ADP-ribosyltransferase 4 (Dombrock blood group)Blood group antigen proteins
CD markers
Enzymes
Predicted membrane proteins
Predicted secreted proteins
Rods & RingsTissue enhanced
ATP1B3ATPase Na+/K+ transporting subunit beta 3CD markers
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Plasma membraneLiver cancer: 6.32e-6
Renal cancer: 1.29e-5
Endometrial cancer: 5.19e-5
Expressed in all
BCAMBasal cell adhesion molecule (Lutheran blood group)Blood group antigen proteins
CD markers
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Nucleoli fibrillar centerRenal cancer: 5.94e-6
Endometrial cancer: 1.24e-5
Colorectal cancer: 2.31e-4
Expressed in all
BMPR1ABone morphogenetic protein receptor type 1ACancer-related genes
CD markers
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
CytosolLiver cancer: 8.93e-4
Glioma: 9.38e-4
Mixed
BMPR1BBone morphogenetic protein receptor type 1BCD markers
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Endometrial cancer: 2.84e-4
Tissue enhanced
BSGBasigin (Ok blood group)Blood group antigen proteins
CD markers
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
VesiclesRenal cancer: 1.95e-6
Liver cancer: 5.48e-6
Endometrial cancer: 2.59e-4
Expressed in all
BST1Bone marrow stromal cell antigen 1CD markers
Enzymes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhanced
BST2Bone marrow stromal cell antigen 2CD markers
Plasma proteins
Predicted membrane proteins
Golgi apparatus
Plasma membrane
Cytosol
Renal cancer: 3.56e-9
Testis cancer: 4.22e-4
Breast cancer: 6.69e-4
Expressed in all
BTLAB and T lymphocyte associatedCD markers
Predicted intracellular proteins
Predicted membrane proteins
Group enriched
BTN3A1Butyrophilin subfamily 3 member A1CD markers
Predicted membrane proteins
Predicted secreted proteins
VesiclesRenal cancer: 4.15e-5
Urothelial cancer: 4.81e-4
Expressed in all
C5AR1Complement C5a receptor 1CD markers
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Renal cancer: 1.16e-4
Cervical cancer: 4.71e-4
Testis cancer: 7.99e-4
Ovarian cancer: 9.55e-4
Tissue enhanced
CCR1C-C motif chemokine receptor 1CD markers
G-protein coupled receptors
Predicted membrane proteins
Renal cancer: 1.01e-4
Tissue enhanced
CCR2C-C motif chemokine receptor 2CD markers
G-protein coupled receptors
Predicted membrane proteins
Lung cancer: 5.87e-4
Tissue enhanced
CCR3C-C motif chemokine receptor 3CD markers
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Mixed
CCR4C-C motif chemokine receptor 4CD markers
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
CCR5C-C motif chemokine receptor 5 (gene/pseudogene)CD markers
Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Endometrial cancer: 7.42e-5
Head and neck cancer: 9.33e-5
Mixed
CCR6C-C motif chemokine receptor 6CD markers
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
CCR7C-C motif chemokine receptor 7Cancer-related genes
CD markers
G-protein coupled receptors
Predicted membrane proteins
MitochondriaHead and neck cancer: 7.61e-7
Cervical cancer: 8.03e-6
Breast cancer: 3.84e-4
Testis cancer: 7.72e-4
Group enriched
CCR8C-C motif chemokine receptor 8CD markers
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
CCR9C-C motif chemokine receptor 9CD markers
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Group enriched
CD101CD101 moleculeCD markers
Predicted membrane proteins
MitochondriaTissue enhanced
CD109CD109 moleculeCD markers
Plasma proteins
Predicted membrane proteins
Stomach cancer: 7.96e-5
Renal cancer: 2.65e-4
Urothelial cancer: 4.68e-4
Tissue enriched
CD14CD14 moleculeCancer-related genes
CD markers
Plasma proteins
Predicted secreted proteins
VesiclesRenal cancer: 6.80e-5
Expressed in all
CD151CD151 molecule (Raph blood group)Blood group antigen proteins
CD markers
Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Liver cancer: 5.58e-4
Thyroid cancer: 6.92e-4
Lung cancer: 9.46e-4
Expressed in all
CD160CD160 moleculeCD markers
Predicted secreted proteins
Tissue enhanced
CD163CD163 moleculeCD markers
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Plasma membraneOvarian cancer: 7.27e-4
Mixed
CD163L1CD163 molecule like 1CD markers
Predicted intracellular proteins
Predicted membrane proteins
Nucleoplasm
Centrosome
Cytosol
Tissue enhanced
CD164CD164 moleculeCD markers
Disease related genes
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
CD180CD180 moleculeCD markers
Predicted membrane proteins
Tissue enhanced
CD19CD19 moleculeCD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Group enriched
CD1ACD1a moleculeCD markers
Predicted membrane proteins
Cervical cancer: 6.37e-4
Group enriched
CD1BCD1b moleculeCD markers
Predicted membrane proteins
Tissue enhanced
CD1CCD1c moleculeCD markers
Predicted intracellular proteins
Predicted membrane proteins
Cervical cancer: 1.79e-5
Tissue enhanced
CD1DCD1d moleculeCancer-related genes
CD markers
Predicted membrane proteins
Endoplasmic reticulumRenal cancer: 2.12e-5
Mixed
CD1ECD1e moleculeCD markers
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CD2CD2 moleculeCD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Renal cancer: 4.82e-6
Endometrial cancer: 1.69e-5
Melanoma: 3.97e-5
Head and neck cancer: 7.46e-5
Cervical cancer: 1.47e-4
Breast cancer: 4.36e-4
Ovarian cancer: 7.72e-4
Tissue enhanced
CD200CD200 moleculeCD markers
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Mixed
Page of 8 | next »